MYD88 L265P somatic mutation: Its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders

American Journal of Clinical Pathology

Volumn 140, Issue 3, 2013, Pages 387-394

  Ondrejka, Sarah L ^a   Lin, Jeffrey J ^a   Warden, Doug W ^a   Durkin, Lisa ^a   Cook, James R ^a   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bone marrow; Lymphoplasmacytic lymphoma; Marginal zone lymphoma; MYD88; Waldenstr m macroglobulinemia

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88;

ADULT; AGED; B CELL LYMPHOMA; BONE MARROW BIOPSY; CHRONIC LYMPHATIC LEUKEMIA; DIFFERENTIAL DIAGNOSIS; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; SPLENIC MARGINAL ZONE LYMPHOMA; WALDENSTROEM MACROGLOBULINEMIA;

BONE MARROW; LYMPHOPLASMACYTIC LYMPHOMA; MARGINAL ZONE LYMPHOMA; MYD88; WALDENSTRÖM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOID DIFFERENTIATION FACTOR 88; RETROSPECTIVE STUDIES; WALDENSTROM MACROGLOBULINEMIA;

EID: 84882786151     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP10ZCLFZGYZIP     Document Type: Review

References (39)

1. Swerdlow S, Berger F, Pileri S, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:194-195.
2. Bartl R, Frisch B, Mahl G, et al. Bone marrow histology in Waldenström's macroglobulinaemia: clinical relevance of subtype recognition. Scand J Haematol. 1983;31:359-375.
3. Remstein ED, Hanson CA, Kyle RA, et al. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenström's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol. 2003;30:182-186.
4. Heerema-McKenney A, Waldron J, Hughes S, et al. Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma. Am J Clin Pathol. 2010;133:265-270.
5. Lin P, Hao S, Handy BC, et al. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients. Am J Clin Pathol. 2005;123:200-205.
6. Schop RF, Kuehl WM, Van Wier SA, et al. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood. 2002;100:2996-3001.
7. Mansoor A, Medeiros LJ, Weber DM, et al. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001;116:543-549.
8. Braggio E, Dogan A, Keats JJ, et al. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities. Mod Pathol. 2012;25:651-660.
9. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910-1916.
10. Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med. 2012;367:826-833.
11. Cook JR, Hsi ED, Worley S, et al. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival. Am J Clin Pathol. 2006;125:615-624.
12. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327:291-295.
13. Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011;470:115-119.
14. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490:116-120.
15. Montesinos-Rongen M, Godlewska E, Brunn A, et al. Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma. Acta Neuropathol. 2011;122:791-792.
16. Pham-Ledard A, Cappellen D, Martinez F, et al. MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol. 2012;132:2118-2120.
17. Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475:101-105.
18. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011;365:2497-2506.
19. Gachard N, Parrens M, Soubeyran I, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 2012;27:183-189.
20. Landgren O, Staudt L. MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med. 2012;367:2255-2257.
21. Franco V, Florena AM, Campesi G. Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma. Histopathology. 1996;29:571-575.
22. Arcaini L, Varettoni M, Boveri E, et al. Distinctive clinical and histological features of Waldenstrom's macroglobulinemia and splenic marginal zone lymphoma. Clin Lymphoma Myeloma Leuk. 2011;11:103-105.
23. Inamdar KV, Medeiros LJ, Jorgensen JL, et al. Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am J Clin Pathol. 2008;129:714-722.
24. Schenka AA, Gascoyne RD, Duchayne E, et al. Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma. Hum Pathol. 2003;34:789-791.
25. Costes V, Duchayne E, Taib J, et al. Intrasinusoidal bone marrow infiltration: a common growth pattern for different lymphoma subtypes. Br J Haematol. 2002;119:916-922.
26. Lin P, Medeiros LJ. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: an evolving concept. Adv Anat Pathol. 2005;12:246-255.
27. Varettoni M, Arcaini L, Zibellini S, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström's macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121:2522-2528.
28. Yan Q, Huang Y, Watkins AJ, et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica. 2012;97:595-598.
29. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncol. 2003;30:110-115.
30. Anderson KC, Alsina M, Bensinger W, et al. Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. J Natl Compr Canc Netw. 2012;10:1211-1219.
31. Lin P, Mansoor A, Bueso-Ramos C, et al. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: clinicopathologic features of 12 cases. Am J Clin Pathol. 2003;120:246-253.
32. Roulland S, Navarro JM, Grenot P, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006;203:2425-2431.
33. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99:3806-3812.
34. Miranda RN, Briggs RC, Kinney MC, et al. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Mod Pathol. 2000;13:1308-1314.
35. Mozos A, Royo C, Hartmann E, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555-1562.
36. Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305-2315.
37. Warden DW, Ondrejka S, Lin J, et al. Phospho- ERKTHR202/Tyr214 is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections. Am J Surg Pathol. 2013;37:305-308.
38. Tandon B, Peterson L, Gao J, et al. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Mod Pathol. 2011;24:1433-1443.
39. Warden D, Ondrejka S, Durkin L, et al. The utility of LEF-1 immunohistochemical stain in the diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol. 2012;25:379a.